Cargando…
Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease
The metalloproteinase family of a disintegrin and metalloproteinase with thrombospondin motifs-7 (ADAMTS-7) was reported to be a novel locus associated with human coronary artery disease. This study aimed to investigate plasma ADAMTS-7 levels in stable obstructive CAD patients and elucidate the rela...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134802/ https://www.ncbi.nlm.nih.gov/pubmed/27902619 http://dx.doi.org/10.1097/MD.0000000000005523 |
_version_ | 1782471525309349888 |
---|---|
author | Yu, Jie Zhou, Boda Yu, Haiyi Han, Jiangli Cui, Ming Zhang, Fuchun Wang, Guisong Guo, Lijun Gao, Wei |
author_facet | Yu, Jie Zhou, Boda Yu, Haiyi Han, Jiangli Cui, Ming Zhang, Fuchun Wang, Guisong Guo, Lijun Gao, Wei |
author_sort | Yu, Jie |
collection | PubMed |
description | The metalloproteinase family of a disintegrin and metalloproteinase with thrombospondin motifs-7 (ADAMTS-7) was reported to be a novel locus associated with human coronary artery disease. This study aimed to investigate plasma ADAMTS-7 levels in stable obstructive CAD patients and elucidate the relationship between plasma ADAMTS-7 levels and the severity of CAD assessed by the Syntax score. This was a single center cross-sectional study performed in 182 CAD patients. ELISA was used to measure plasma ADAMTS-7 levels. All patients were divided into subgroup according to the ADAMTS-7 median in this cohort: high group with ADAMTS-7 ≥0.99 ng/mL and low group with ADAMTS-7 <0.99 ng/mL. Furthermore, all patients were divided into tertiles according to their Syntax scores (low group: Syntax score ≤10.0; moderate group: 10.0 <Syntax score ≤18.0; high group: Syntax score >18.0). We followed up the participants continuously until the first major adverse cardiovascular event (MACE) for a mean time of 22.0 months. Plasma ADAMTS-7 levels in the high Syntax score group were significantly higher compared with the low Syntax score group (3.29 [0.08–26.3] ng/mL vs 1.24 [0.15–8.78] ng/mL, P = 0.010). Plasma ADAMTS-7 levels were significantly positively correlated with the Syntax score tertiles (r = 0.157, P = 0.035). Logistic regression analysis indicated that the plasma ADAMTS-7 level was one of the independent predictors for the Syntax score tertiles (B = 1.118, 95% CI: 1.194–7.830, P = 0.020), together with HbA1c (B = 0.946, 95% CI: 1.248–5.312, P = 0.010), uric acid (B = –0.019, 95% CI: 0.974–0.988, P<0.001), and coronary artery calcium score (B = –0.001, 95% CI: 0.998–0.999, P < 0.001). Compared with the low ADAMTS-7 group, the high ADAMTS-7 group had significantly higher Syntax score (17.10±8.42 vs 14.96 ± 8.11, P = 0.047). Kaplan–Meier analysis showed patients in the high plasma ADAMTS-7 group tend to have a lower event-free survival rate than patients in the low plasma ADAMTS-7 group, unfortunately, no difference was detected (86.8% vs 88.0%, log rank = 0.314, P = 0.575). The plasma ADAMTS-7 level was positively correlated with the Syntax score significantly. The elevated plasma ADAMTS-7 level may be involved in the severity of disease in patients with stable coronary artery disease. |
format | Online Article Text |
id | pubmed-5134802 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-51348022016-12-22 Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease Yu, Jie Zhou, Boda Yu, Haiyi Han, Jiangli Cui, Ming Zhang, Fuchun Wang, Guisong Guo, Lijun Gao, Wei Medicine (Baltimore) 3400 The metalloproteinase family of a disintegrin and metalloproteinase with thrombospondin motifs-7 (ADAMTS-7) was reported to be a novel locus associated with human coronary artery disease. This study aimed to investigate plasma ADAMTS-7 levels in stable obstructive CAD patients and elucidate the relationship between plasma ADAMTS-7 levels and the severity of CAD assessed by the Syntax score. This was a single center cross-sectional study performed in 182 CAD patients. ELISA was used to measure plasma ADAMTS-7 levels. All patients were divided into subgroup according to the ADAMTS-7 median in this cohort: high group with ADAMTS-7 ≥0.99 ng/mL and low group with ADAMTS-7 <0.99 ng/mL. Furthermore, all patients were divided into tertiles according to their Syntax scores (low group: Syntax score ≤10.0; moderate group: 10.0 <Syntax score ≤18.0; high group: Syntax score >18.0). We followed up the participants continuously until the first major adverse cardiovascular event (MACE) for a mean time of 22.0 months. Plasma ADAMTS-7 levels in the high Syntax score group were significantly higher compared with the low Syntax score group (3.29 [0.08–26.3] ng/mL vs 1.24 [0.15–8.78] ng/mL, P = 0.010). Plasma ADAMTS-7 levels were significantly positively correlated with the Syntax score tertiles (r = 0.157, P = 0.035). Logistic regression analysis indicated that the plasma ADAMTS-7 level was one of the independent predictors for the Syntax score tertiles (B = 1.118, 95% CI: 1.194–7.830, P = 0.020), together with HbA1c (B = 0.946, 95% CI: 1.248–5.312, P = 0.010), uric acid (B = –0.019, 95% CI: 0.974–0.988, P<0.001), and coronary artery calcium score (B = –0.001, 95% CI: 0.998–0.999, P < 0.001). Compared with the low ADAMTS-7 group, the high ADAMTS-7 group had significantly higher Syntax score (17.10±8.42 vs 14.96 ± 8.11, P = 0.047). Kaplan–Meier analysis showed patients in the high plasma ADAMTS-7 group tend to have a lower event-free survival rate than patients in the low plasma ADAMTS-7 group, unfortunately, no difference was detected (86.8% vs 88.0%, log rank = 0.314, P = 0.575). The plasma ADAMTS-7 level was positively correlated with the Syntax score significantly. The elevated plasma ADAMTS-7 level may be involved in the severity of disease in patients with stable coronary artery disease. Wolters Kluwer Health 2016-12-02 /pmc/articles/PMC5134802/ /pubmed/27902619 http://dx.doi.org/10.1097/MD.0000000000005523 Text en Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-No Derivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0 |
spellingShingle | 3400 Yu, Jie Zhou, Boda Yu, Haiyi Han, Jiangli Cui, Ming Zhang, Fuchun Wang, Guisong Guo, Lijun Gao, Wei Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease |
title | Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease |
title_full | Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease |
title_fullStr | Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease |
title_full_unstemmed | Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease |
title_short | Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease |
title_sort | association between plasma adamts-7 levels and severity of disease in patients with stable obstructive coronary artery disease |
topic | 3400 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134802/ https://www.ncbi.nlm.nih.gov/pubmed/27902619 http://dx.doi.org/10.1097/MD.0000000000005523 |
work_keys_str_mv | AT yujie associationbetweenplasmaadamts7levelsandseverityofdiseaseinpatientswithstableobstructivecoronaryarterydisease AT zhouboda associationbetweenplasmaadamts7levelsandseverityofdiseaseinpatientswithstableobstructivecoronaryarterydisease AT yuhaiyi associationbetweenplasmaadamts7levelsandseverityofdiseaseinpatientswithstableobstructivecoronaryarterydisease AT hanjiangli associationbetweenplasmaadamts7levelsandseverityofdiseaseinpatientswithstableobstructivecoronaryarterydisease AT cuiming associationbetweenplasmaadamts7levelsandseverityofdiseaseinpatientswithstableobstructivecoronaryarterydisease AT zhangfuchun associationbetweenplasmaadamts7levelsandseverityofdiseaseinpatientswithstableobstructivecoronaryarterydisease AT wangguisong associationbetweenplasmaadamts7levelsandseverityofdiseaseinpatientswithstableobstructivecoronaryarterydisease AT guolijun associationbetweenplasmaadamts7levelsandseverityofdiseaseinpatientswithstableobstructivecoronaryarterydisease AT gaowei associationbetweenplasmaadamts7levelsandseverityofdiseaseinpatientswithstableobstructivecoronaryarterydisease |